The G protein G o is highly expressed in neurons and mediates effects of a group of rhodopsin-like receptors that includes the opioid, ␣ 2 -adrenergic, M2 muscarinic, and somatostatin receptors. In vitro, G o is also activated by growth cone-associated protein of M r 43,000 (GAP43) and the Alzheimer amyloid precursor protein, but it is not known whether this occurs in intact cells. G o is an ␣␤␥ heterotrimeric G protein discovered in 1984 in brain by Neer and collaborators (1, 2) and by Sternweis and Robishaw (3), who all characterized it as a substrate for the ADP-ribosyltransferase activity of pertussis toxin. G o has received special attention for the following reasons: (i) It is the most abundant G protein in neurons, where it can constitute up to 2% of membrane protein (3). (ii) In addition to neurons, it appears to be expressed only on endocrine cells and heart, albeit at much lower levels comparable to those of the other heterotrimeric G proteins. (iii) G o is activated not only by the same class of seven-transmembrane receptors that activate the inhibitory G proteins G i1 -G i3 (4-9) but also by at least two proteins that do not belong to the rhodopsin-like family of G protein-coupled receptors, GAP43, an intracellular growth cone-associated protein active in neurite outgrowth (10), and the Alzheimer amyloid protein precursor protein responsible for familial forms of this disease (11). (iv) Except for inhibition of neuronal Ca 2ϩ channels, for which the mechanism of action of G o has been elucidated at the molecular level and shown to be due to the interaction of its ␤␥ moiety with the ␣ 1 subunit of the channel (6, 12-16), the mode of action of G o is essentially unknown. Tests for an ␣ i -like function for ␣ o have failed (17, 18) . Activated ␣ o has transformed NIH-3T3 cells (19) and activated mitogen-activated protein kinase activity in Chinese hamster ovary cells (20), phospholipase C in Xenopus oocytes, and K ϩ channels in neurons (21, 22), but how these effects come about has not been established. In fact, there is scant knowledge of the gamut of effector systems that may be the target(s) of activated G o .
G o is an ␣␤␥ heterotrimeric G protein discovered in 1984 in brain by Neer and collaborators (1, 2) and by Sternweis and Robishaw (3), who all characterized it as a substrate for the ADP-ribosyltransferase activity of pertussis toxin. G o has received special attention for the following reasons: (i) It is the most abundant G protein in neurons, where it can constitute up to 2% of membrane protein (3). (ii) In addition to neurons, it appears to be expressed only on endocrine cells and heart, albeit at much lower levels comparable to those of the other heterotrimeric G proteins. (iii) G o is activated not only by the same class of seven-transmembrane receptors that activate the inhibitory G proteins G i1 -G i3 (4) (5) (6) (7) (8) (9) but also by at least two proteins that do not belong to the rhodopsin-like family of G protein-coupled receptors, GAP43, an intracellular growth cone-associated protein active in neurite outgrowth (10) , and the Alzheimer amyloid protein precursor protein responsible for familial forms of this disease (11) . (iv) Except for inhibition of neuronal Ca 2ϩ channels, for which the mechanism of action of G o has been elucidated at the molecular level and shown to be due to the interaction of its ␤␥ moiety with the ␣ 1 subunit of the channel (6, (12) (13) (14) (15) (16) , the mode of action of G o is essentially unknown. Tests for an ␣ i -like function for ␣ o have failed (17, 18) . Activated ␣ o has transformed NIH-3T3 cells (19) and activated mitogen-activated protein kinase activity in Chinese hamster ovary cells (20) , phospholipase C in Xenopus oocytes, and K ϩ channels in neurons (21, 22) , but how these effects come about has not been established. In fact, there is scant knowledge of the gamut of effector systems that may be the target(s) of activated G o .
Gene ablation in mice is a powerful yet technically complex approach to identify as yet unknown functions of proteins that become manifest in mutated animals and͞or in cell lines derived from them. It has been applied to several G proteins with the following interesting results. G i2 -deficient mice were found to develop ulcerative colitis and adenocarcinomas, revealing an unexpected and as yet unexplained role of G i2 in the development of a chronic inflammatory response and very likely in lymphocyte homing to enteric epithelia (23, 24) . Ablation of G q revealed an essential role for this G protein in platelet activation, because G q -deficient mice bleed and their platelets fail to be activated by physiologic activators such as collagen, thrombin, thromboxane, and ADP (25) . Also the ablation of G o has been reported (26) . Live mice, homozygous for loss of ␣ o , were obtained showing that ␣ o is not essential for life in spite of the features that set it apart from other G proteins. Mice lacking G o were not like wild-type mice, however. They had a generalized tremor of unknown etiology and died at a very early postnatal ages. At the cellular level, G o -deficient mice displayed a loss of muscarinic inhibition of isoproterenol-stimulated cardiac L type Ca 2ϩ currents. The latter finding was unexpected, given that the present view is that this channel in particular is insensitive to inhibition by a G protein-coupled pathway; specifically, it does not interact with G protein ␤␥ dimers that inhibit the neuronal non-L type Ca 2ϩ channels (16, 27, 28) . We have also used homologous recombination in embryonic stem cells to abolish its expression. The most prominent but not necessarily the most important of our findings is that G o -deficient mice develop a turning behavior as if afflicted by unilateral lesions of the central nervous system.
MATERIALS AND METHODS
Vector and Cell Development. The intron exon structure of the gene encoding ␣ o has been elucidated (refs. 29 and 30 and Fig. 1 ). The ␣ o gene was disrupted in embryonic stem cells with previously described procedures and selection markers [Rudolph et al. (23, 33) ]. 129Sv genomic DNA was obtained from a P1 cosmid selected from a commercial library (Genome Systems, St. Louis) by PCR screening with oligonucleotides A and B (where A is 5Ј-GGACAGCCTGGATCGGATTGG, a fragment of the sense strand of ␣ o exon 5, and B is 5Ј-ACCTGGTCATAGCCGCTGAGT, a fragment of the antisense strand of ␣ o exon 6) as primers (amplified fragment, 940 bp). A 10.8-kb HindIII-SalI fragment containing exons 5, 6, 7.2, and part of 8.2 was used to construct a targeting vector. The final vector had a pBSII backbone (Stratagene) and contained a 4.2-kb HindIII-BamHI fragment separated from 2.1-kb BamHI fragment of the ␣ o gene by a Pol I-neomycin selection cassette (ref. 34 and Fig. 1 ). The MC1-tk counterselection marker was placed at the 5Ј end (35) . This vector was transfected by electroporation into AB2.2 embryonic stem cells (from Allan Bradley, Baylor College of Medicine), and candidate recombinant clones were selected by growth on leukemia inhibitory factor-producing SNL feeder layers (also from Allan Bradley) in the presence of G418 (active ingredient; GIBCO͞BRL; 180 g͞ml) and 0.2 M 1-(2-deoxy-2-f luoro-␤-D-arabinofuranosyl)-5-iodouracil (Moravek Biochemicals, Brea, CA). All cells were grown in DMEM containing glucose (4.5 g͞liter), 2 mM glutamine, 15% heatinactivated fetal bovine serum (GIBCO͞BR L), 1% 2-mercaptoethanol, penicillin (100 units͞ml), and streptomycin (100 g͞ml) (GIBCO͞BRL). Recombinant clones were identified by Southern blot analysis using a 1.2-kb BamHIXhoI 3Ј external probe. After confirming the insertion of the Pol II-neomycin cassette into the BamHI site of the ␣ o gene and absence of secondary insertions, the targeted 129Sv embryonic stem cells were injected into C57BL͞6J blastocysts from which chimeric mice were derived. Two (129Sv ϫ C57BL͞6J) F 1 cross-bred mouse strains heterozygous for loss of G o ␣ were obtained from two chimeric (F 0 ) mice and these FIG. 1. Genomic organization of the gene encoding Go ␣ subunits and design of the disruption. (A) Intron-exon boundaries of the cDNA coding for Go␣ and location of key amino acid sequences. Boxes, exons; open boxes, untranslated sequences; solid or hatched boxes, translated sequences. Exon numbering is shown below and the number of the last amino acid of each exon is shown above the cDNA. Amino acids in G1 through G5 regions are responsible for binding and hydrolysis of GTP (31) . Mutations in R* and Q* of G2 and G3 reduce GTPase activity (32) . Pertussis toxin (PTX) ADP ribosylates a Cys at position Ϫ4 from C terminus. (B) Genomic structure of the Go␣ gene (29, 30) , structure of the targeting vector, 3Ј and 5Ј probes for Southern blot analysis, and expected restriction fragment sizes of the wild-type and the mutated alleles.
FIG. 2.
Genotype and ADP-ribosylation patterns of wild-type and ␣oϪ͞Ϫ mice. (A) Southern blot analysis of XhoI-digested DNA from tail biopsies of Ϫ͞Ϫ mice and ϩ͞Ϫ and ϩ͞ϩ littermates; the probe was the 3Ј external probe shown in Fig. 1. (B) Selected tissues from wild-type mice and mice predicted by Southern blot analysis to be Go-deficient. Homogenizations were all in 27% sucrose͞1 mM EDTA͞10 mM Tris⅐HCl, pH 7.5. Homogenates were ADP-ribosylated without further processing in the presence of guanosine 5Ј-[␤-thio]diphosphate, adenosine 5Ј-[␤,␥-imido]triphosphate, 0.1% SDS, and 2 mM DTT for 30 min at 32°C in a final volume of 15 l as described (36) . NAD was then added to give 4 mM, mixed with 30 l of 2ϫ Laemmli's sample buffer, and separated by urea-gradient SDS͞PAGE in 9% gels (36) . The gels were stained and destained over night and autoradiographed. Except for brain, the predominant bands are ␣i2. Note that in the pituitary the intensities of ␣o1 and ␣o2 (above and below ␣i2) are about equivalent; in brain, ␣o1 is the predominant band with ␣i1/3 and ␣i2 being similar in intensity. In heart ventricle homogenates, only the ␣i2 band is evident [absent in ␣i2-deficient hearts (37)]. were bred to homozygosity (F 2 mice) for loss of G o ␣ (␣ o Ϫ͞Ϫ mice, Fig. 2A ).
Genotyping. Southern blot analysis was performed according to Sambrook et al. (38) with DNA isolated from tail biopsies. The 3Ј external probe was a 1.8-kb BamHI-XhoI fragment, and the 5Ј probe was the 4.2-kb HindIII-BamHI fragment used to construct the vector. The plasmid pBluescript KSII, the PolII-Neo cassette and the MC1-tk cassette were used to probe for absence of these sequences in the targeted embryonic stem cell. Probes were labeled with [ 32 P]dCTP by using the random priming method (39) . For hybridization, DNA digests were depurinated and transferred onto GeneScreenPlus membranes (NEN͞Dupont). The filters were baked at 80°C under vacuum, washed for 1 h at 65°C with 2ϫ SSC (1ϫ SSC ϭ 150 mM NaCl͞15 mM sodium citrate, pH 7.0), and prehybridized in 0.5 M sodium phosphate͞7% SDS͞1% BSA͞0.5 mM EDTA, pH 7.2, for 4-6 h at 65°C. Hybridization was at the same temperature in the same solution containing the heat-denatured probes at 2-10 ϫ 10 6 cpm͞ml. After 15 h, the filters were washed for four 5-min periods with 0.5ϫ SSC͞0.1% SDS at room temperature and for two 15-min periods at 65°C. The membranes were autoradiographed by using Kodak BioMax MR films. The PCR was also used to genotype DNA samples. Amplification conditions were 1 min at 94°C, 2 min at 64°C, and 3 min at 72°C for 35 cycles with oligonucleotides A and B for wild-type DNA (940 bp) and C and B for mutant DNA (where C is 5Ј-CAATGGCCGATC-CCATATTGGCTGC, an antisense fragment located in the coding region of the neomycin gene; 700 bp) as primers.
Isolation of Dorsal Root Ganglion (DRG) Cells and Recording of Voltage-Gated Ca 2؉ Channel Currents. Sensory neurons were obtained from the lumbar and thoracic dorsal root ganglia of adult mice. Ganglia were enzymatically treated and mechanically dispersed as described (40), except that the ganglia were not desheathed and that collagenase treatment was 90 min. DRG neurons were plated onto laminin͞ ornithine-coated glass coverslips and incubated overnight in MEM containing 10% fetal bovine serum and mouse nerve growth factor (2.5 S; 10-20 ng͞ml) at 37°C, 90% humidity, and 3% CO 2 before recording.
Voltage-clamp recordings were performed within 30 h of plating by using an Axopatch 200A amplifier (Axon Instruments, Foster City, CA) in the whole-cell patch configuration as described (39) . Data were filtered with a 4-pole Bessel filter and digitized. Series resistance, 0.3-5 M⍀, was estimated from the settling rate of the voltage clamp and the membrane capacitance and was compensated (Ͼ80%) by using amplifier circuitry. Only data obtained from neurons in which uncompensated series resistance resulted in voltage-clamp errors of less than 5 mV were used. A P͞4 protocol was used for leak subtraction. To ensure the linearity of leakage currents around the holding potential for the P͞4 protocol, the resting conductance for each cell was determined at potentials between Ϫ100 and Ϫ60 mV. Data were fit with a nonlinear least-square method.
Ba 2ϩ was used as the charge carrier. The bath solution contained 130 mM choline chloride, 2.5 mM BaCl 2 , 0.6 mM MgCl 2 , 10 mM Hepes, and 10 mM glucose (pH was adjusted to 7.4 with Tris base and osmolarity was adjusted with sucrose to 325 milliosmolar). The electrode solution contained 140 mM CsCl, 0.1 mM CaCl 2 , 2 mM MgCl 2 , 11 mM EGTA, 10 mM Hepes, 2 mM Mg-ATP, and 1 mM Li-GTP (pH was adjusted to 7.2 with Tris base and osmolarity was adjusted with sucrose to 310 milliosmolar). Patch pipettes filled with electrode solution had resistances of 2-6 M⍀.
Whole-cell impedance and capacitance of each cell were estimated by stepping the membrane potential to Ϫ90 mV for four 10-ms periods and measuring the area under the transient associated with the voltage step. Ba 2ϩ currents were evoked from a holding potential of Ϫ70 mV by 40-ms steps to 0 mV every 10 s. Currents were sampled at 50 kHz and filtered at 5 kHz. [D-Ala,N-MePhe 4 ,Gly-ol]Enkephalin (DAMGO at 1 M, dissolved in bath solution; from Research Biochemicals) was applied for 1-2 min, and its effect was determined as a percent change in peak evoked current (39) or, with a prepulse potentiation protocol, as an increase in peak current after a depolarizing step to ϩ80 mV for 100 ms (prepulse) preceding a 30-ms test depolarization to Ϫ5 mV initiated 10 ms after the end of the prepulse. Conductance-voltage curves were constructed for each neuron from instantaneous tail currents evoked at Ϫ70 mV after 40-ms voltage steps between Ϫ80 and ϩ50 mV taken at every 5 mV. Current density was estimated by dividing the peak current evoked at the start of the experiment by the cell capacitance and did not differ in neurons from ␣ o ϩ͞ϩ and ␣ o Ϫ͞Ϫ mice (data not shown).
ADP Ribosylation of Membrane Particles from Murine
Other procedures used to ADP-ribosylate and separate the ADP-ribosylated proteins by urea and polyacrylamide gradient gel electrophoresis (urea-gradient SDS͞PAGE) were as described (40) .
Adenylyl cyclase activity was assayed in murine ventricular heart muscle homogenates as described (41) .
RESULTS AND DISCUSSION
Disruption of the Gene Encoding ␣ o Variants. Two G o ␣ subunit cDNAs, derived from alternatively spliced mRNAs, have been identified by molecular cloning: ␣ o1 , encoded in exons 1 through 6 plus 7.1, 8.1, and 9 (42-44); and ␣ o2 , encoded in exons 1 through 6 plus 7.2 and 8.2 (45, 46) . ␣ o1 and ␣ o2 differ in 26 amino acids dispersed along their last 111 amino acids (total length, 354 amino acids; Fig. 1 A) . In urea-gradient SDS͞PAGE gels, ADP-ribosylated ␣ o1 migrates very close but slightly behind ADP-ribosylated ␣ i2 , which it often occludes, and ADP-ribosylated ␣ o2 migrates slightly ahead of ADPribosylated ␣ i2 (47) . A posttranslational modification of unknown nature generates a third ␣ o (␣ oC ) that comigrates in SDS͞PAGE gels with ␣ o2 (47, 48) . Fig. 1 shows the intronexon organization of the G o ␣ gene (29, 30) and the structural features of the insertion vector constructed to disrupt this gene. The neomycin selection cassette was inserted into exon 6, which is common to both splice variants, and thus prevents synthesis of all forms of G o .
Intercrosses of ϩ͞Ϫ mice yielded G o -deficient mice (␣ o Ϫ͞Ϫ mice). ␣ o Ϫ͞Ϫ mice had DNA with the expected restriction endonuclease pattern (e.g., Fig. 2 A) and, by ADP ribosylation of brain, pituitary, pancreatic islet, and cardiac membranes, showed the expected loss of G o proteins (Fig. 2B) . No difference in ADP-ribosylation pattern was seen in tissues not expressing G o ␣ (e.g., thymus, spleen, liver, lung, and exocrine pancreas). A comparison of the pituitary and brain ADPribosylation patterns clearly shows that, relative to ␣ o1 , ␣ o2 is more abundant in the pituitary.
␣ o ؊͞؊ Mice: Inheritance of the Disruption and Poor Survival. Thirty-eight embryos resulting from four ϩ͞Ϫ ϫ ϩ͞Ϫ crosses were genotyped at embryonic days 18-20. We found 8 Ϫ͞Ϫ, 14 ϩ͞Ϫ, and 15 ϩ͞ϩ mice (22, 38, and 40%, respectively), indicating an under-representation of embryos with one or two disrupted alleles ( 2 test, P Ͼ 0.05). Loss of Ϫ͞Ϫ mice became very noticeable after birth. Thus, at weaning we had 348 live mice from 46 litters: 21 Ϫ͞Ϫ, 177 ϩ͞Ϫ, and 105 ϩ͞ϩ mice, for a distribution of 7, 58, and 35%, respectively. This distribution indicates early death of Ϫ͞Ϫ mice. Also, 3-week-old Ϫ͞Ϫ animals are small, with a mean body weight that is only 45% the weight of their littermates. Weaned Ϫ͞Ϫ animals are unable to feed well by themselves in standard cages either because of the small size or because of general weakness. However, they eat food supplied as a paste on a dish and, those that survive, grow well so that by 8 weeks they have a body weight that does not differ from that of their littermates (Fig. 3A) . Weight and growth characteristics of ␣ o ϩ͞Ϫ mice are indistinguishable from those of wild-type littermates. Fig.  3B shows the survival curve of 31 ␣ o Ϫ͞Ϫ mice starting after the first postnatal week; by 7 weeks 50% had died of unknown reasons. Two survived for more than 50 weeks. When subjected to hot-plate tests, ␣ o Ϫ͞Ϫ animals were found to be hyperalgesic (Fig. 3C) (13) , and the spinal analgesic effect of opioids has been proposed to be due, at least in part, to inhibition of presynaptic Ca 2ϩ channels in the afferent pathway. This was based on the ability of opioids to inhibit the evoked release of neurotransmitter (49) and their ability to inhibit neuronal Ca 2ϩ channels thought to be located at presynaptic terminals (27) . We thus tested whether opioidreceptor-mediated inhibition of Ca 2ϩ currents in sensory DRGs would be affected by loss of G o . As shown in Fig. 4 , lack of G o resulted in a partial (30%, P Ͻ 0.05) loss of the inhibitory effect of the -selective opioid receptor agonist DAMGO. This indicates that inhibition of these type of currents is not solely mediated by G o (Fig. 4) . We noted further that in 7 of 31 ␣ o Ϫ͞Ϫ cells examined, the position of the conductancevoltage relationship was shifted by Ϫ13.3 Ϯ 1.7 mV. Whether the combination of the reduced response to G i ͞G o -coupled receptors and the shift in activation voltage are related to and͞or responsible for the hyperalgesia seen in hot-plate tests or whether the hyperalgesia is rooted in some other change(s) in neuronal sensitivity remains to be determined.
The opioid receptor-induced inhibition of neuronal non-L type Ca 2ϩ currents is thought to be the direct consequence of the ␤␥ dimer of G o interacting with the ␣ 1 Ca 2ϩ channel subunit (for review, see ref. 50; see also ref. 16 ). The ''prepulse facilitation'' protocol was applied to test whether the inhibition seen in the absence of G o was still mediated by ␤␥ dimers. This test is based on the observation that inhibition of Ca 2ϩ current by the ␦-opioid receptor in NG108-15 cells is very pronounced at low test potentials, Ϫ20 to 0 mV, but wanes at higher test potentials (12) . This phenomenon is common for the effects of G i ͞G o -coupled receptors including the type B ␥-aminobutryic acid receptor in chicken DRG cells (51) and the ␣ 2 -adrenergic receptor in PC12 cells (52) . In the ''prepulse'' protocol, receptor agonist is added to the bath, time is given to allow for installment of channel inhibition, and channel activity is recorded. First, the inhibited state is measured in response to a test pulse, and then it is remeasured after a strong depolarizing pulse to ϩ80 mV or higher (prepulse), which relieves the inhibition exerted by receptor stimulation. Later studies have shown that inhibition is mediated by G␤␥ and that loss of inhibition after the prepulse is simply because of dissociation of G␤␥ from the channel's ␣ 1 subunit. Repolarization allows for rebinding of G␤␥ and reinstallment of the inhibition (e.g., refs. 28, 53, and 54). As shown in Fig. 4C , the Ca 2ϩ current recorded in the presence of the -opioid receptor agonist DAMGO was ''potentiated,'' i.e., uninhibited, by a prepulse. This proved the effective installment of channel inhibition through the ␤␥ arm of the G protein-coupled pathway. (56, 57) , and with intact cells (58) , it is now recognized that G i proteins inhibit adenylyl cyclase activities through their activated ␣ i subunits. However, when compared with ␣ i subunits, the very similar ␣ o subunits do not appear to inhibit adenylyl cylcases (17, 18) . The report of Valenzuela et al. (26) , who in ␣ o Ϫ͞Ϫ mice showed loss of carbachol-induced inhibition of isoproterenol-stimulated cardiac Ca 2ϩ currents, raised the possibility that the M2 muscarinic receptor in ventricle cells might be acting by reducing the levels of cAMP, which stimulates this G␤␥-insensitive channel, and that this reduction of cAMP levels might come about by activation of G o . The possibility existed that loss of the carbachol action was caused by a loss in its ability to reduce adenylyl cyclase activty and thus that G o might be acting as a G i and inhibit adenylyl cyclase in cardiac ventriculocytes to the exclusion of G i , perhaps because of a colocalization phenomenon. However, we found that carbachol (100 M) inhibits cardiac adenylyl cyclase equally well in ␣ o ϩ͞ϩ and ␣ o Ϫ͞Ϫ homogenates [55 Ϯ 3% inhibition for ␣ o ϩ͞ϩ (n ϭ 4) vs. 52 Ϯ 4% (n ϭ 3) for ␣ o Ϫ͞Ϫ; mean Ϯ SD; data not shown). This indicated that whatever the mechanism is by which G odeficient mice lose muscarinic regulation of Ca 2ϩ currents, it is not because of loss of regulation of cardiac adenylyl cyclase and points to yet another form of regulation of this effector system that is controlled by G o by an unknown mechanism.
Lack of Increase in
Motor Control. As reported (26), we also noted that ␣ o Ϫ͞Ϫ mice have a generalized tremor. This tremor is accompanied by impairment of motor control. Thus, when placed on a rotating rod (rotarod) 4.5 cm in diameter, ␣ o Ϫ͞Ϫ mice showed a marked deficiency in coordinated motor movement and a tendency to fall off, even from the stationary rod. None stayed on the rotating rod for more than 5 s (Fig. 3D) . Likewise, when placed on a 1-m beam that was 1 inch wide (1 inch ϭ 2.54 cm), ␣ o Ϫ͞Ϫ mice generally did not walk along it or, when they did, they did so hesitantly and fell off after just a few paces.
Hyperactivity and Turning Behavior. Because of the impaired motor control, it was surprising to observe a higher level of activity in cages with ␣ o Ϫ͞Ϫ mice. On closer observation, we noticed that Ϫ͞Ϫ mice appeared to be moving continuously. We thus placed Ϫ͞Ϫ mice individually into a box with the bottom covered with an approximately 1-inch-thick layer of washed and sterilized sand from the beach of Santa Monica, CA. Wild-type and ϩ͞Ϫ mice behaved the same: walked for the most part along the sides of the box, stopped, reared, groomed, and inspected each corner. G o ␣ Ϫ͞Ϫ mice, in contrast, after a short delay during which they moved tentatively and slowly, gradually accelerated their walk, ignored corners, and were soon (within 1-2 min) running in circles. Depending on the individual, these circles were large and close to the periphery or, for 80% of the mice, changed continuously in diameter covering the complete surface of the box in a nonsystematic way. Thus, Ϫ͞Ϫ mice display a turning behavior that was not seen in wild-type or ϩ͞Ϫ mice. We videotaped the movements of the mice, replayed the tape on a 9-inch television set, and traced the paths onto transparencies. Fig. 5 shows the paths of one ϩ͞ϩ, one ϩ͞Ϫ, and one Ϫ͞Ϫ mouse and the superposition of the paths of five animals of each group. Once they had started turning, Ϫ͞Ϫ mice continued to do so at varying speeds. In a circular field 18 inches in diameter, the fastest (2155M) run 162.7 Ϯ 20 circles (or ovals) (mean Ϯ SD, n ϭ 3) in 6 min (one every 2-3 s); the slowest made 25.5 Ϯ 3.3 large circles in 6 min. Running is not totally continuous. The mice make short stops to defecate, resume running, stop shortly to inspect, and smell their droppings the next time by, and also stop for short grooming events-licking their coats and stroking their whiskers with their front paws. Otherwise ␣ o Ϫ͞Ϫ mice run for hours on end. Short records of their turning behavior can be seen at http:͞͞rfh.anes.ucla.edu͞ ϳlutzb͞realmice.htm. (requires REALPLAY software, which is down-loadable free of cost). The ␣ o Ϫ͞Ϫ mice see: they avoid objects and other mice placed in their paths. Interactions with littermates (Ϫ͞Ϫ, also running, ϩ͞Ϫ, or ϩ͞ϩ) do occur and are friendly but hasty. Ϫ͞Ϫ animals eat and drink but do so also with haste. Neither Ϫ͞Ϫ females nor Ϫ͞Ϫ males have mated successfully. A histological examination of serial coronal sections of the brains of ␣ o Ϫ͞Ϫ mice (fixed in 4% formalin, 5 m thick at 100-m intervals, stained with Luxol fast blue and counterstained with cresyl violet) revealed no obvious anatomical left-right differences.
In summary, G o -deficient mice show an array of defects that span from the molecular (e.g., unexpected defects and alterations in the regulation of Ca 2ϩ currents) to the integrative (e.g., impaired motor control and extreme turning behavior). Elucidation of the biochemical and cellular mechanisms affected by loss of G o is expected to lead to insights into cell signaling and homeostatic controls. 
